Acorda Therapeutics reported $395.6M in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US USD 587.81M 14.68M
Acorda Therapeutics ACOR:US USD 395.6M 2.26M
Agios Pharmaceuticals AGIO:US USD 1.24B 58.4M
Amgen AMGN:US USD 65.12B 1.42B
Anika Therapeutics ANIK:US USD 349.13M 1.38M
Aptinyx Inc APTX:US USD 76.2M 16.1M
Arrowhead Research ARWR:US USD 891.49M 199.55M
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Cara Therapeutics CARA:US USD 182.24M 31.27M
Clovis Oncology CLVS:US USD 346.78M 46.08M
Cytokinetics CYTK:US USD 1.01B 61.19M
Enanta Pharmaceuticals ENTA:US USD 347.53M 27.88M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
Heron Therapeutics HRTX:US USD 250.95M 21M
Insmed INSM:US USD 1.66B 661.62M
Ligand Pharmaceuticals LGND:US USD 762.67M 287.94M
Mannkind MNKD:US USD 295.28M 1.44M
Merck MRK:GR EUR 48.53B 2.41B
Moderna Inc MRNA:US USD 25.86B 198M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Novartis NOVN:VX USD 117.45B 1.01B
Teva Pharmaceutical TEVA:IT USD 44.01B 246M
Ultragenyx Pharmaceutical RARE:US USD 1.55B 73.03M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B